Jalen Hurts is expected to miss the remainder of the 2026 season, according to multiple reports, after blood clots were found in his lungs. The Eagles and Hurts' agent, Nicole Lynn, issued a joint statement on Monday laying out his updated diagnosis after originally announcing he had a superficial blood clot in his left calf that caused him to miss Week 6. A follow-up scan over the weekend revealed deep vein thrombosis, and he had "bilateral pulmonary emboli," meaning several blood clots were now in his lungs.
The Eagles said Hurts' prognosis is "very good" and that he is expected to make a full recovery. However, he will be treated with blood thinners, which will take him away from football activities until he is off the treatment. "Over the last few days, Jalen Hurts has received comprehensive medical evaluations by physician experts.
In the interest of transparency, we are providing additional information on the diagnosis and treatment plan related to his condition. "Jalen was initially diagnosed by specialists in London with a left calf superficial vein thrombosis. After further testing and monitoring, the current diagnosis is a deep vein thrombosis, as well as bilateral pulmonary emboli.
He is clinically stable and has no significant functional limitations. His treatment should only involve anticoagulation (i.e. During this time, he will not be allowed to participate in any contact activities, including football.
"Jalen's prognosis is very good, and we expect a full recovery. We anticipate that he will have the opportunity to resume contact football activities when off the blood thinners. In the meantime, he will remain active around the team and continue to condition.
More importantly, we anticipate that he will have no long-term effects. "We are thinking of Jalen and looking forward to a strong recovery." No clots were found until Hurts was in London. It was initially diagnosed as a superficial blood clot.
Extract — continue reading at the source.
